Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted (TCD) hematopoietic stem cell transplants (HSCT) for the treatment of myeloid malignancies Meeting Abstract

  

Authors:	Boulad, F.; Jakubowski, A.; Papadopoulos, E.; Hsu, K. C.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; Chiu, M.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Small, T. N.; Castro-Malaspina, H.; O'Reilly, R. J.
Abstract Title:	Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted (TCD) hematopoietic stem cell transplants (HSCT) for the treatment of myeloid malignancies
Meeting Title:	49th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	110
Issue:	11 Pt. 1
Meeting Dates:	2007 Dec 8-11
Meeting Location:	Atlanta, GA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2007-11-01
Start Page:	878A
Language:	English
ACCESSION:	WOS:000251100804028
PROVIDER:	wos
PUBMED:	18092369
DOI:	10.1182/blood.V110.11.2991.2991
Notes:	--- - Meeting Abstract: 2991 - 49th Annual Meeting of the American-Society-of-Hematology - DEC 08-11, 2007 - Atlanta, GA - Part 1 - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/25378